Published ahead of print on June 12, 2003, doi:10.1165/rcmb.2003-0078OC
Am. J. Respir. Cell Mol. Biol., Volume 29, Number 6, December 2003, 743-749
A more recent version of this article appeared on December 1, 2003
Submitted on March 18, 2003
Revised on June 11, 2003
Pulmonary and Activation-Regulated Chemokine Stimulates Collagen Production in Lung Fibroblasts
Sergei P Atamas1*, Irina G Luzina2, Jung Choi3, Natalya Tsymbalyuk3, Nicholas H Carbonetti4, Ishwar S Singh2, Maria Trojanowska5, Sergio A Jimenez6, and Barbara White1
1 Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA; Research Service, Veterans Affairs Maryland Health Care System, Baltimore, MD, USA,
2 Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Research Service, Veterans Affairs Maryland Health Care System, Baltimore, MD, USA,
3 Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA,
4 Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA,
5 Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, USA,
6 Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA
* To whom correspondence should be addressed. E-mail: satamas{at}umaryland.edu.
Levels of pulmonary and activation-regulated chemokine (PARC) mRNA and protein are increased in the lungs of patients with pulmonary fibrosis. The purpose of this work was to establish whether PARC could be directly involved in development of pulmonary fibrosis by stimulating collagen production in lung fibroblasts. Exposure to PARC increased production of collagen mRNA and protein by three to four fold in normal adult lung and dermal fibroblast cells. Collagen mRNA transiently increased after 3 to 6 hours of activation with PARC, with an increase in collagen protein detected after 24 hours of activation. At the same time, PARC had less pronounced effect on fibroblast proliferation, not exceeding 50% increase over control non-stimulated cells. PARC intracellular signaling led to activation of ERK 1/2, but not p38, in fibroblasts; pharmacological inhibition of ERK, but not p38, also blocked PARC's effect on collagen production. Inhibition experiments with pertussis toxin suggested that PARC receptor is G protein-coupled. Thus, PARC is a member of the CC chemokine family that acts directly as a profibrotic factor.
This article has been cited by other articles:

|
 |

|
 |
 
N. Nacu, I. G. Luzina, K. Highsmith, V. Lockatell, K. Pochetuhen, Z. A. Cooper, M. P. Gillmeister, N. W. Todd, and S. P. Atamas
Macrophages Produce TGF-{beta}-Induced ({beta}-ig-h3) following Ingestion of Apoptotic Cells and Regulate MMP14 Levels and Collagen Turnover in Fibroblasts
J. Immunol.,
April 1, 2008;
180(7):
5036 - 5044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.O. Kraaijeveld, S.C.A. de Jager, W.J. de Jager, B.J. Prakken, S.R. McColl, I. Haspels, H. Putter, T.J.C. van Berkel, L. Nagelkerken, J.W. Jukema, et al.
CC Chemokine Ligand-5 (CCL5/RANTES) and CC Chemokine Ligand-18 (CCL18/PARC) Are Specific Markers of Refractory Unstable Angina Pectoris and Are Transiently Raised During Severe Ischemic Symptoms
Circulation,
October 23, 2007;
116(17):
1931 - 1941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W T van Lieshout, J. Fransen, M. Flendrie, A. M M Eijsbouts, F. H J van den Hoogen, P. L C M van Riel, and T. R D J Radstake
Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis
Ann Rheum Dis,
October 1, 2007;
66(10):
1334 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Pochetuhen, I. G. Luzina, V. Lockatell, J. Choi, N. W. Todd, and S. P. Atamas
Complex Regulation of Pulmonary Inflammation and Fibrosis by CCL18
Am. J. Pathol.,
August 1, 2007;
171(2):
428 - 437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Pierce, K. Carpenter, C. Jakubzick, S. L. Kunkel, H. Evanoff, K. R. Flaherty, F. J. Martinez, G. B. Toews, and C. M. Hogaboam
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21
Eur. Respir. J.,
June 1, 2007;
29(6):
1082 - 1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. M. Wang, Y. Zhang, H. P. Kim, Z. Zhou, C. A. Feghali-Bostwick, F. Liu, E. Ifedigbo, X. Xu, T. D. Oury, N. Kaminski, et al.
Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
J. Exp. Med.,
December 25, 2006;
203(13):
2895 - 2906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wimmer, S. K. Khaldoyanidi, M. Judex, N. Serobyan, R. G. DiScipio, and I. U. Schraufstatter
CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effect on monocytes
Blood,
December 1, 2006;
108(12):
3722 - 3729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. Luzina, K. Highsmith, K. Pochetuhen, N. Nacu, J. N. Rao, and S. P. Atamas
PKC{alpha} Mediates CCL18-Stimulated Collagen Production in Pulmonary Fibroblasts
Am. J. Respir. Cell Mol. Biol.,
September 1, 2006;
35(3):
298 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. d. Nadai, A.-S. Charbonnier, C. Chenivesse, S. Senechal, C. Fournier, J. Gilet, H. Vorng, Y. Chang, P. Gosset, B. Wallaert, et al.
Involvement of CCL18 in Allergic Asthma
J. Immunol.,
May 15, 2006;
176(10):
6286 - 6293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Prasse, D. V. Pechkovsky, G. B. Toews, W. Jungraithmayr, F. Kollert, T. Goldmann, E. Vollmer, J. Muller-Quernheim, and G. Zissel
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Am. J. Respir. Crit. Care Med.,
April 1, 2006;
173(7):
781 - 792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kulka, N. Fukuishi, M. Rottem, Y. A. Mekori, and D. D. Metcalfe
Mast cells, which interact with Escherichia coli, up-regulate genes associated with innate immunity and become less responsive to Fc{epsilon}RI-mediated activation
J. Leukoc. Biol.,
February 1, 2006;
79(2):
339 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Schutyser, A. Richmond, and J. Van Damme
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes
J. Leukoc. Biol.,
July 1, 2005;
78(1):
14 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Tourkina, P. Gooz, J. Pannu, M. Bonner, D. Scholz, S. Hacker, R. M. Silver, M. Trojanowska, and S. Hoffman
Opposing Effects of Protein Kinase C{alpha} and Protein Kinase C{epsilon} on Collagen Expression by Human Lung Fibroblasts Are Mediated via MEK/ERK and Caveolin-1 Signaling
J. Biol. Chem.,
April 8, 2005;
280(14):
13879 - 13887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Masaki, C. Stambe, P. A. Hill, J. Dowling, R. C. Atkins, and D. J. Nikolic-Paterson
Activation of the Extracellular-Signal Regulated Protein Kinase Pathway in Human Glomerulopathies
J. Am. Soc. Nephrol.,
July 1, 2004;
15(7):
1835 - 1843.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society.
|
|
|